262372-13-4

Upstream product

• 66224-66-6 adenine 
• 262372-07-6 (1S,4S,5R)-5-benzoyl-4-benzoylmethylcyclohex-2-en-1-ol 
• 262372-08-7 (1S,2S,3R,5R)-3-benzoyl-2-benzoylmethyl-1,5-di(tert-butyldimethylsilyloxy)cyclohexane 
• 262372-10-1 (1S,2S,3R,5S)-3-benzoyl-2-benzoylmethyl-5-(tert-butyldimethylsilyloxy)-1-(methanesulfonyloxy)cyclohexane 
• 262372-09-8 (1S,2S,3R,5S)-3-benzoyl-2-benzoylmethyl-5-(tert-butyldimethylsilyloxy)cyclohexanol 
• 262372-11-2 (1R,3S,4S,5R)-5-benzoyl-4-benzoylmethyl-3-(methanesulfonyloxy)cyclohexanol 
• 262372-12-3 (4S,5R)-5-benzoyl-4-benzoylmethylcyclohex-2-en-1-one 
• 262372-05-4 (1R,2S,3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-hydroxymethyl-cyclohexanol 
• 93-97-0 benzoic acid anhydride 

Relevant academic research and scientific papers

The cyclohexene ring system as a furanose mimic: Synthesis and antiviral activity of both enantiomers of cyclohexenylguanine

Both enantiomers of cyclohexenylguanine were synthesized in a stereospecific way starting from the same starting material: R-(-)-carvone. Both compounds showed potent and selective anti-herpesvirus activity (HSV-1, HSV-2, VZV, CMV). The binding of both cy